Cargando…

Characterization of Extensively Drug-Resistant (XDR) Carbapenemase-Producing Enterobacterales (CPE) in Canada from 2019 to 2020

Data regarding the epidemiology of extensively drug-resistant (XDR) carbapenemase-producing Enterobacterales (CPE) in Canada are scarce. Among CPE patients identified by the Canadian Nosocomial Infection Surveillance Program, the following were each significantly associated with XDR status: internat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bartoszko, Jessica J., Mitchell, Robyn, Katz, Kevin, Mulvey, Michael, Mataseje, Laura
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430190/ https://www.ncbi.nlm.nih.gov/pubmed/35950772 http://dx.doi.org/10.1128/spectrum.00975-22

Ejemplares similares

837. Contamination of Hospital Drains by Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada
por: Jamal, Alainna J, et al.
Publicado: (2020)

2468. The Genomic Epidemiology of Carbapenemase-Producing Enterobacterales (CPE) in Ontario, Canada, 2016
por: Jamal, Alainna J, et al.
Publicado: (2023)

1228. Risk Factors for Contamination with Carbapenemase-Producing Enterobacteriales (CPE) in Exposed Hospital Drains in Ontario, Canada
por: Jamal, Alainna, et al.
Publicado: (2019)

Incidence and Time-to-Onset of Carbapenemase-Producing Enterobacterales (CPE) Infections in CPE Carriers: a Retrospective Cohort Study
por: Hoellinger, B., et al.
Publicado: (2022)

Risk Factors Associated with Carbapenemase-Producing Enterobacterales (CPE) Positivity in the Hospital Wastewater Environment
por: Park, Stacy C., et al.
Publicado: (2020)

Reflections on a national public health emergency response to carbapenemase-producing Enterobacterales (CPE)
por: Humphreys, Hilary, et al.
Publicado: (2022)

512. Healthcare-Acquired (HA) Carbapenemase-Producing Enterobacteriales (CPE) in Southern Ontario, Canada: To Whom Are We Transmitting CPE?
por: Jamal, Alainna, et al.
Publicado: (2019)

501. Risk of Infection in Persons Colonized with Carbapenemase-Producing Enterobacteriales (CPE) in Ontario, Canada
por: Faheem, Amna, et al.
Publicado: (2019)

89. On-going impact of the SARS-CoV-2 pandemic on the evolution of carbapenemase-producing Enterobacterales in Ontario, Canada
por: Mozafarihashjin, Mohammad, et al.
Publicado: (2022)

Knowledge, attitudes and self-reported practices of healthcare professionals on Carbapenemase Producing Enterobacterales (CPE): A cross sectional study
por: Paul Mathew, Shaini, et al.
Publicado: (2022)

1186. Prevalence of Carbapenemase-Producing Enterobacteriaceae (CPE) in Hospital Drains in Southern Ontario
por: Jamal, Alainna, et al.
Publicado: (2018)

Corrigendum: Carbapenemase-producing Enterobacteriaceae (CPE) isolated from pigs in China
por: Tong, Man-Ki, et al.
Publicado: (2019)

Treating infections caused by carbapenemase-producing Enterobacterales (CPE): a pragmatic approach to antimicrobial stewardship on behalf of the UKCPA Pharmacy Infection Network (PIN)
por: Hughes, Stephen, et al.
Publicado: (2020)

SG-APSIC1118: Introduction of carbapenemase-producing Enterobacterales (CPE) in the aqueous environment of the newly built National Centre for Infectious Diseases (NCID) in Singapore
por: Ong, Chong Hui Clara, et al.
Publicado: (2023)

Audit and feedback as a tool to increase compliance with carbapenemase-producing Enterobacteriaceae (CPE) screening and decrease CPE transmission in the hospital
por: Ben Natan, Orna, et al.
Publicado: (2023)

The Changing Epidemiology of Carbapenemase-Producing Enterobacterales
por: Hussein, Khetam, et al.
Publicado: (2022)

Epidemiology of carbapenem-resistant and carbapenemase-producing Enterobacterales in the Netherlands 2017–2019
por: Wielders, Cornelia C. H., et al.
Publicado: (2022)

First Report of OXA-181-Producing Enterobacterales Isolates in Latin America
por: Cuicapuza, Diego, et al.
Publicado: (2023)

Treatment of infections caused by carbapenemase-producing Enterobacterales
por: Íñigo, Melania, et al.
Publicado: (2022)

1226. Two consecutive outbreaks of carbapenemase-producing enterobacteriaceae (CPE) in a pediatric hospital
por: Mor, Meirav, et al.
Publicado: (2022)

Hospital effluent: A reservoir for carbapenemase-producing Enterobacterales?
por: Cahill, Niamh, et al.
Publicado: (2019)

Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan
por: Habib, Amina, et al.
Publicado: (2022)

Evaluation of a novel procedure for rapid detection of carbapenemase-producing Enterobacteriaceae (CPE) using the LightMix(®) modular carbapenemase kits
por: Oviaño, Marina, et al.
Publicado: (2016)

In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
por: Karlowsky, James A., et al.
Publicado: (2022)

503. Comparison of IMP Carbapenemase-Producing Enterobacteriaceae (CPE) and Non-Carbapenemase-Producing Enterobacteriaceae: A Multicenter Prospective Study of Clinical and Molecular Epidemiology in Japan
por: Hayakawa, Kayoko, et al.
Publicado: (2019)

Molecular epidemiology of carbapenemase-producing Enterobacterales in Finland, 2012–2018
por: Räisänen, Kati, et al.
Publicado: (2020)

Association of Carbapenemase-Producing Enterobacterales Detected in Stream and Clinical Samples
por: Sung, Gyung-Hye, et al.
Publicado: (2022)

Paradoxical consequences of wastewater interventions targeting carbapenemase-producing Enterobacterales
por: Lehman, David, et al.
Publicado: (2023)

2760. Fecal Microbiota Transplantation for Decolonization of Carbapenemase-Producing Enterobacterales
por: Davido, Benjamin, et al.
Publicado: (2023)

Investigation of a Carbapenemase-producing Acinetobacter baumannii outbreak using whole genome sequencing versus a standard epidemiologic investigation
por: Bogaty, Chloe, et al.
Publicado: (2018)

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014
por: Mataseje, Laura F., et al.
Publicado: (2016)

The acceptability of screening for Carbapenemase Producing Enterobacteriaceae (CPE): cross-sectional survey of nursing staff and the general publics’ perceptions
por: Currie, Kay, et al.
Publicado: (2018)

The potential of visible blue light (405 nm) as a novel decontamination strategy for carbapenemase-producing enterobacteriaceae (CPE)
por: Halstead, Fenella D., et al.
Publicado: (2019)

Identification and Preliminary Hierarchisation of Selected Risk Factors for Carbapenemase-Producing Enterobacteriaceae (CPE) Colonisation: A Prospective Study
por: Timler, Małgorzata, et al.
Publicado: (2023)

Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19
por: Farfour, Eric, et al.
Publicado: (2020)

Present and Future Perspectives on Therapeutic Options for Carbapenemase-Producing Enterobacterales Infections
por: Vrancianu, Corneliu Ovidiu, et al.
Publicado: (2021)

Predominance of Non-carbapenemase Producing Carbapenem-Resistant Enterobacterales in South Texas
por: Black, Cody A., et al.
Publicado: (2021)

Multicenter Study of Carbapenemase-Producing Enterobacterales in Havana, Cuba, 2016–2021
por: Yu, Haiyang, et al.
Publicado: (2022)

Temporal and regional incidence of carbapenemase-producing Enterobacterales, Switzerland, 2013 to 2018
por: Ramette, Alban, et al.
Publicado: (2021)

Whole genome sequencing reveals hidden transmission of carbapenemase-producing Enterobacterales
por: Marimuthu, Kalisvar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_htmqhb6m5bqr6ju5t0jrrqvtkk